Cadrenal Therapeutics, Inc. (CVKD) vs Onconetix, Inc. (ONCO)
Cadrenal Therapeutics, Inc. and Onconetix, Inc. are both Biotechnology companies. Cadrenal Therapeutics, Inc. and Onconetix, Inc. are of similar size ($4.6M and $4.3M). Cadrenal Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Onconetix, Inc. trades at 0.0×. Cadrenal Therapeutics, Inc. has the higher net margin (0.00% vs −1,578.6%) and the lower return on invested capital (−427.5% vs −135.4%). Across the 13 metrics below, Onconetix, Inc. leads on 8 and Cadrenal Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | CVKD | ONCO | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 80.38% | 65.16% |
| Operating margin | 0.00% | (2,524.73%) | 0.00% |
| Net margin | 0.00% | (1,578.60%) | 0.00% |
| Free cash flow margin | 0.00% | (1,595.90%) | 0.00% |
| Return on equity | (275.16%) | (105.23%) | (57.72%) |
| Return on assets | (199.59%) | (57.37%) | (49.22%) |
| Return on invested capital | (427.54%) | (135.42%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack